fouremm,,,,,,It is an assumption that Eastern/Hepalink are interested in being the manufacturer and distributors of RVXs' epigenetic drugs now and the future. What is there, 7 more molecules ready to be released for trials! I dont think they intend to flip shares. Is there $$ in the manufacturing process? Probably. Contract the manufacturing out 3rd party possibly if margins are small? We anticipate major margins on sales, correct. Hepalink distributes its product internationally to pharmas. So, I think the infrasturcuture already exists to move 208. Manufacturing capacity would be next on the agenda, but I am sure there is ample opportunity out there to take care of that side of things. Billonaires tend to have the resources to make deals where others cant. Time will tell if another partner comes on board. But my thinking is licensing deals only. The entire investment is being looked at at all angles by these insiders where $$$ can be made to drive revenues. They can afford time perhaps more than us retailers as well. I am hoping they do make RVX a pharma,,cha ching,,jmo